Drug Antitrust

PHILADELPHIA — A federal judge refused to dismiss the Rochester Drug Cooperative’s claim that Johnson & Johnson violated more than a dozen states’ consumer-protection laws by monopolizing the market for Remicade, an arthritis drug, via exclusive agreements and coercive bundled rebates.

%d bloggers like this: